TY - JOUR
T1 - RhoA and Rho kinase regulate the epithelial Na+/H+ exchanger NHE3. Role of myosin light chain phosphorylation
AU - Szászi, Katalin
AU - Kurashima, Kazuyoshi
AU - Kapus, András
AU - Paulsen, Anders
AU - Kaibuchi, Kozo
AU - Grinstein, Sergio
AU - Orlowski, John
PY - 2000/9/15
Y1 - 2000/9/15
N2 - The activity of the Na+/H+ exchanger NHE3 isoform, which is found primarily in epithelial cells, is sensitive to the state of actin polymerization. Actin assembly, in turn, is controlled by members of the small GTPase Rho family, namely Rac1, Cdc42, and RhoA. We therefore investigated the possible role of these GTPases in modulating NHE3 activity. Cells stably expressing NHE3 were transiently transfected with inhibitory forms of Rac1, Cdc42, or RhoA and transport activity was assessed using microfluorimetry. NHE3 activity was not adversely affected by either dominant-negative Rac1 or Cdc42. By contrast, the inhibitory form of RhoA greatly depressed NHE3 activity, without noticeably altering its subcellular distribution. NHE3 activity was equally reduced by inhibiting p160 Rho-associated kinase I (ROK), a downstream effector of RhoA, with the selective antagonist Y-27632 and a dominant-negative form of ROK. Furthermore, inhibition of ROK reduced the phosphorylation of myosin light chain. A comparable net dephosphorylation was achieved by the myosin light chain kinase inhibitor ML9, which similarly inhibited NHE3. These data suggest that optimal NHE3 activity requires a functional RhoA-ROK signaling pathway which acts, at least partly, by controlling the phosphorylation of myosin light chain and, ultimately, the organization of the actin cytoskeleton.
AB - The activity of the Na+/H+ exchanger NHE3 isoform, which is found primarily in epithelial cells, is sensitive to the state of actin polymerization. Actin assembly, in turn, is controlled by members of the small GTPase Rho family, namely Rac1, Cdc42, and RhoA. We therefore investigated the possible role of these GTPases in modulating NHE3 activity. Cells stably expressing NHE3 were transiently transfected with inhibitory forms of Rac1, Cdc42, or RhoA and transport activity was assessed using microfluorimetry. NHE3 activity was not adversely affected by either dominant-negative Rac1 or Cdc42. By contrast, the inhibitory form of RhoA greatly depressed NHE3 activity, without noticeably altering its subcellular distribution. NHE3 activity was equally reduced by inhibiting p160 Rho-associated kinase I (ROK), a downstream effector of RhoA, with the selective antagonist Y-27632 and a dominant-negative form of ROK. Furthermore, inhibition of ROK reduced the phosphorylation of myosin light chain. A comparable net dephosphorylation was achieved by the myosin light chain kinase inhibitor ML9, which similarly inhibited NHE3. These data suggest that optimal NHE3 activity requires a functional RhoA-ROK signaling pathway which acts, at least partly, by controlling the phosphorylation of myosin light chain and, ultimately, the organization of the actin cytoskeleton.
UR - http://www.scopus.com/inward/record.url?scp=0034665980&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034665980&partnerID=8YFLogxK
U2 - 10.1074/jbc.M001193200
DO - 10.1074/jbc.M001193200
M3 - Article
C2 - 10893221
AN - SCOPUS:0034665980
SN - 0021-9258
VL - 275
SP - 28599
EP - 28606
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 37
ER -